LIF, but not IL-6, regulates osteoprogenitor differentiation in rat calvaria cell cultures: Modulation by dexamethasone

Journal of Bone and Mineral Research

Volumn 13, Issue 2, 1998, Pages 175-184

  Malaval, Luc ^a   Gupta, Ashwani K ^b,c   Liu, Fina ^b,d   Delmas, Pierre D ^a   Aubin, Jane E ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITY OF TORONTO   (Canada)

^c NPS Pharmaceutical Inc   (United States)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DEXAMETHASONE; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; FETUS; GENE EXPRESSION REGULATION; HORMONAL REGULATION; NONHUMAN; OSTEOBLAST; RAT; STEM CELL;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINE RECEPTOR GP130; DEXAMETHASONE; DOWN-REGULATION; GLUCOCORTICOIDS; GROWTH INHIBITORS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; OSTEOGENESIS; POLYMERASE CHAIN REACTION; RATS; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKULL; STEM CELLS;

EID: 0031937224     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.2.175     Document Type: Article

References (48)

1. Horowitz MC, Levy JB 1995 The LIF/IL6 subfamily of cytokines induces protein phosphorylation and signal transduction by nonreceptor tyrosine kinases in human and murine osteoblasts. Calcif Tissue Int 56:S32-S34.
2. Hibi M, Nakajima K, Hirano T 1996 IL-6 cytokine family and signal transduction: A model of the cytokine system. J Mol Med-Jmm 74:1-12.
3. Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling - Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311.
4. Martin TJ, Allan EH, Evely RS, Reid IR 1992 Leukaemia inhibitory factor and bone cell function. In: Block GR, Widdows K (eds.) Polyfunctional Cytokines: IL-6 and LIF (Ciba Foundation Symposium), Vol 167. Wiley, Chichester, U.K., pp. 141-155.
5. Bellows CG, Aubin JE, Heersche JNM, Antosz ME 1986 Mineralized bone nodules formed from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38:143-154.
6. Aubin JE, Turksen K, Heersche JNM 1993 Osteoblast cell lineage. In: Noda M (eds.) Molecular and Cellular Biology of Bone. Academic Press, San Diego, CA, U.S.A., pp. 1-45.
7. Bhargava U, Bar-Lev M, Bellows CG, Aubin JE 1988 Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells. Bone 9:155-163.
8. Malaval L, Gupta AK, Aubin JE 1995 Leukemia inhibitory factor (LIF) inhibits osteogenic differentiation in rat calvaria cell cultures. Endocrinology 136:1411-1418.
9. Bellows CG, Aubin JE, Heersche JNM 1986 Physiological concentration of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 121:1985-1992.
10. Hughes FJ, Howells GL 1993 Interleukin-6 inhibits bone formation in vitro. Bone Miner 21:21-28.
11. Hughes FJ, Howells GL 1993 Interleukin-11 inhibits bone formation in vitro. Calcif Tissue Int 53:362-364.
12. Rao LG, Ng B, Brunette DM, Heersche JNM 1977 Parathyroid hormone- and prostaglandin E1-response in a selected population of bone cells after repeated subculture and storage at -8O°C. Endocrinology 100:1233-1241.
13. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
14. Patterson PH, Fann M-J 1992 Further studies of the distribution of CDF/LIF mRNA. In: Block GR, Widdows K (eds.) Polyfunctional Cytokines: IL-6 and LIF (Ciba Foundation Symposium), Vol 167. Wiley, Chichester, U.K., pp. 125-140.
15. Northemann W, Braciak TA, Hattori M, Lee F, Fey G 1989 Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J Biol Chem 264:16072-16082.
16. Saito M, Yoshida K, Hibi M, Taga T, Kishimoto T 1992 Molecular cloning of a murine IL-6 receptor associated signal transducer, gp130, and its regulated expression in vivo. J Immunol 148:4066-4071.
17. Fiorillo MT, Toniatti C, Van Snick J, Ciliberto G 1992 Expression of the murine interleukin 6 receptor in hepatoma cells: The intracytoplasmic domain is not required for interleukin 6 signal transduction. Eur J Immunol 22:799-804.
18. Tomida M, Yamamoto-Yamagushi Y, Hozumi M 1994 Three diferent cDNAs encoding mouse D-factor/LIF receptor. J Biochem 115:557-562.
19. Stahl J, Gearing DP, Willson TA, Brown MA, King JA, Gough NM 1990 Structural organization of the genes for murine and human leukemia inhibitory factor: Evolutionary conservation of coding and non-coding regions. J Biol Chem 265:8833-8841.
20. Monk RJ, Meyuha O, Perry RP 1981 Mammals have multiple genes for individual ribosomal proteins. Cell 24:301-306.
21. Brackenhoff JB, Degroot JER, Evers RF, Pannekock H, Aarden LA 1987 Molecular cloning and expression of hybridoma growth factor in E. coli. J Immunol 139:41-46.
22. Weichert H, Blechshmidt I, Schröder S, Ambrosius H 1991 The MTT-assay as a rapid test for cell proliferation and cell killing: Application to human peripheral blood lymphocytes (PBL). Allerg Immunol 37:139-144.
23. Vink A, Coulie P, Warnier G, Renauld JC, Stevens M, Donckers D, Van Snick J 1990 Mouse plasmacytoma growth in vivo: Enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor. J Exp Med 172:997-1000.
24. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamagushi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T 1990 IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303.
25. Bellido T, Stahl N, Farruggella TJ, Borba V, Yancopoulos GD, Manolagas SC 1996 Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest 97:431-437.
26. Tobler A, Meier R, Seitz M, Dewald B, Baggiolini M, Fay MF 1992 Glucocorticoids down regulate gene expression of GM-CSF, NAP-1/IL8, and IL6, but not of M-CSF in human fibroblasts. Blood 79:45-51.
27. Beuninger LM, Dempsey WL, Uhl J, Murasko DM 1993 Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes. Clin Immunol Immunopathol 69:205-214.
28. Grosset C, Jazwiec B, Taupin JL, Liu H, Richard S, Mahon FX, Reiffers J, Moreau JF, Ripoche J 1995 In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: Differential regulation by interleukin-1 alpha and glucocorticoids. Blood 86:3763-3770.
29. Haynesworth SE, Baber MA, Caplan AJ 1996 Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1α. J Cell Pysiol 166:585-592.
30. Tanabe O, Akira S, Kamiya T, Wong GG, Hirano T, Kishimoto T 1988 Genomic structure of the murine IL-6 gene - High degree conservation of potential regulatory sequences between mouse and human. J Immunol 141:3875-3881.
31. Brattsand R, Linden M 1996 Cytokine modulation by glucocorticoids: Mechanisms and actions in cellular studies. Aliment Pharmacol Ther 10:81-90.
32. Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, Martin TJ, Hirota H, Taga T, Kishimoto T, Suda T 1995 Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 182:1461-1468.
33. Rose-John S, Heinrich PC 1994 Soluble receptors for cytokines and growth factors: Generation and biological function. Biochem J 300:281-290.
34. Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y, Yancopoulos GD, Taga T, Kishimoto T 1993 Soluble forms of the interleukin signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 82:1120-1126.
35. Layton MJ, Bronwyn AC, Metcalf D, Ward LD, Simpson RJ, Nicola NA 1992 A major binding protein for leukemia inhibitory factor in normal mouse serum: Identification as a soluble form of the cellular receptor. Proc Natl Acad Sci USA 89:8616-8620.
36. Villiger PM, Geng Y, Lotz M 1993 Induction of cytokine expression by leukemia inhibitory factor. J Clin Invest 91: 1575-1581.
37. Bellido T, Borba VZC, Stahl N, Yancocoulos G, Jilka RL, Manolagas SC 1995 Ciliary neurotrophic factor (CNTF) and leukemia inhibitory factor (LIF) stimulate cell proliferation and increase alkaline phosphatase and interleukin-6 production by osteoblastic cells. J Bone Miner Res 10:S319.
38. Bellows CG, Aubin JE, Heersche JNM 1991 Initiation and progression of mineralization of bone nodules formed in vitro: The role of alkaline phosphatase and organic phosphate. Bone Miner 14:27-40.
39. Metcalf D, Gearing DP 1989 Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci USA 86:5948-5952.
40. Cornish J, Gallon K, King A, Edgar S, Reid IR 1993 The effects of leukemia inhibitory factor on bone in vivo. Endocrinology 132:1359-1366.
41. Takahashi K, Jilka RL, Manolagas SC 1996 Estrogen loss alters the responsivencss of osteoblast progenitors to leukemia inhibitory factor (LIF). J Bone Miner Res 11:S129.
42. Malaval L, Gupta AK, Aubin JE 1994 Biphasic action of leukemia inhibitory factor on osteogenic differentiation in rat bone marrow stromal cell cultures. Bone Miner 25:S18.
43. Turksen K, Aubin JE 1991 Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J Cell Biol 114:373-384.
44. Herbertson A, Aubin JE 1995 Dexamethasone alters the sub-population make-up of rat bone marrow stromal cell cultures. J Bone Miner Res 10:285-294.
45. Rathjen PD, Toth S, Willis A, Heath JK, Smith AG 1990 Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell 62:1105-1114.
46. Girasole G, Passeri G, Jilka RL, Manolagas SC 1994 Interleukin 11: A new cytokine critical for osteoclast development. J Clin Invest 93:1516-1524.
47. Jay PR, Centrella M, Lorenzo J, Bruce AG, Horowitz MC 1996 Oncostatin M: A new bone active cytokine that activates and inhibits bone resorption. Endocrinology 137:1151-1158.
48. Malik N, Haugen HS, Modrell B, Shoyab M, Clegg CH 1995 Developmental abnormalities in mice transgenic for bovine oncostatin M. Mol Cell Biol 15:2349-2358.